FAM168A and tongue cancer: LYC lowers the levels of tongue cancer and Hepatocellular Carcinoma (HCC) cells TCRP1 protein by promoting the degradation pathway of TCRP1 protein, which translates into repression of Akt/mTOR signaling, and therefore activates apoptotic and autophagic abilities (Yu H. et al., 2017).